Frankfurt
09.01.25
08:02 Uhr
0,001 Euro
-0,015
-96,77 %
-96,77 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.11.24 | IN BRIEF: Polarean Imaging gets FDA approval for MRI chest coil | 4 | Alliance News | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 21.11.24 | Polarean's Xenoview 3T gets new FDA clearance | 1 | Sharecast | ||
| 21.11.24 | Polarean: FDA clears XENOVIEW 3T Chest Coil in GE HealthCare MRI Systems | 5 | GlobeNewswire (USA) | ||
| 21.11.24 | Polarean Imaging PLC - FDA clears Chest Coil in GE HealthCare MRI Systems | 2 | RNS | ||
| 25.09.24 | Polarean Imaging PLC - Virtual investor day | 1 | RNS | ||
| 04.09.24 | Polarean Imaging PLC - Half-year Report | 1 | RNS | ||
| 03.09.24 | Polarean: Appointment of Alan Huang, PhD, as Vice President of Sales | 1 | GlobeNewswire (USA) | ||
| 03.09.24 | Polarean Imaging PLC - Appointment of Vice President of Sales | - | RNS | ||
| 28.08.24 | IN BRIEF: Polarean adds "pulmonary expertise" with new medical chief | 1 | Alliance News | ||
| 28.08.24 | Polarean Imaging plc: Appointment of Chase Hall, M.D., as Chief Medical Advisor | 205 | GlobeNewswire (Europe) | DURHAM, NC and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces... ► Artikel lesen | |
| 28.08.24 | Polarean appoints Xenon MRI specialist as chief medical advisor | 1 | Sharecast | ||
| 28.08.24 | Polarean Imaging PLC - Appointment of Chief Medical Advisor | - | RNS | ||
| 21.08.24 | Polarean Imaging PLC - Notice of Results | 1 | RNS | ||
| 15.08.24 | Polarean Imaging retains co-founder on consultant basis | 1 | Sharecast | ||
| 15.08.24 | Polarean Imaging PLC - Appointment of Bastiaan Driehuys as consultant | - | RNS | ||
| 01.08.24 | Polarean Imaging PLC - FDA submission to expand minimum age for XENOVIEW | - | RNS | ||
| 31.07.24 | Polarean Imaging PLC - New Xenon MRI System trade-in agreement | - | RNS | ||
| 29.07.24 | Polarean Imaging PLC - Repricing of Options and Grant of Options | - | RNS | ||
| 24.07.24 | Polarean Imaging PLC - Result of AGM | - | RNS | ||
| 19.07.24 | Polarean Imaging PLC - Xenon MRI System trade-in agreement | 1 | RNS |
Seite:
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 79,96 | -0,24 % | Kurs der Medtronic Plc-Aktie verharrt auf Vortags-Niveau (78,1311 €) | An der US-amerikanischen Börse ist das Wertpapier von Medtronic Plc aktuell unauffällig. Das Papier notiert zur Stunde bei 80,10 US-Dollar. Ein minimales Kursplus von 0,28 Prozent zeigt die Kurstafel... ► Artikel lesen | |
| HCA HEALTHCARE | 303,00 | +0,43 % | HCA Healthcare's Quarterly Earnings Preview: What You Need to Know | ||
| LANTHEUS | 91,52 | +0,46 % | Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices | ||
| AMEDISYS | 87,50 | -2,23 % | AMEDISYS INC - 8-K, Current Report | ||
| ENVISTA | 18,500 | 0,00 % | Envista Holdings Corporation: Envista Reports Third Quarter 2024 Results | BREA, Calif., Oct. 30, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter of 2024.
For the quarter... ► Artikel lesen | |
| CAREDX | 22,240 | -4,43 % | CareDx, Inc. - 8-K, Current Report | ||
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal First Quarter 2025 Results | Reports 60% Increase in ARR to $17.6 Million, Positive Net Income and Cash Flow, Adjusted EBITDA of $1.3 Million HENDERSON, Nev., Nov. 14, 2024 /PRNewswire/ -- Research Solutions, Inc.... ► Artikel lesen | |
| CARMAT | 1,074 | -0,19 % | CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson Artificial Heart and Anticipates Continued Strong Momentum in 2025 | Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024.
2024 Sales of €7 million (a 2.5-fold increase vs 2023).
Cash burn... ► Artikel lesen | |
| GT BIOPHARMA | 2,570 | -10,45 % | GT Biopharma files for automatic mixed securities shelf | ||
| CHEMOMETEC | 68,90 | +0,36 % | Chemometec A/S: Upgrade of revenue and operating profit guidance | ANNOUNCEMENT NO. 285 3 December 2024 Upgrade of revenue and operating profit guidance ChemoMetec sustained its positive performance in the second quarter of 2024/25 with better-than-expected sales... ► Artikel lesen | |
| HAMILTON THORNE | 1,490 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.12.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.12.2024ISIN NameCA81012R1064 SCOTTIE... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 9,760 | -0,20 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period July to September 2024 | "It is very gratifying to see the impact that we are having in the field of diagnostics. I have just returned from the ASHI event, a major transplantation conference in the US, and it is clear that... ► Artikel lesen | |
| ARRAIL GROUP | 0,264 | -2,22 % | ARRAIL GROUP (06639): 2024/2025 INTERIM REPORT | ||
| SIEMENS HEALTHINEERS | 51,06 | -1,05 % | Siemens denkt um: Healthineers-Aktie unter Druck | Die Siemens-Healthineers-Aktie steht unter Druck. Aussagen des Siemens-Finanzvorstands, den Mehrheitsanteil am Medizintechnik-Spezialisten zu überprüfen, sorgen für Unsicherheiten. Kann Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS | 35,070 | +1,59 % | EQS-News: Formycon AG: Formycon und Fresenius Kabi Canada erhalten Zulassung von Health Canada für FYB202/Otulfi® (Ustekinumab), ein Biosimilar zu Stelara® | EQS-News: Formycon AG
/ Schlagwort(e): Zulassungsgenehmigung
Formycon und Fresenius Kabi Canada erhalten Zulassung von Health Canada für FYB202/Otulfi® (Ustekinumab), ein Biosimilar... ► Artikel lesen |
Das Unternehmen POLAREAN IMAGING PLC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,001 Euro und damit -96,77 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu POLAREAN IMAGING PLC finden Sie auf Wallstreet Online.
